Shanxi Zhendong Pharmaceutical Co.,Ltd (300158.SZ)
CNY 4.78
(-0.21%)
CNY 4.78
(-0.21%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -249.17 Million | 86.3 Million | 284.44 Million | 221.94 Million | 186.35 Million | 154.47 Million |
| Net Income | -47.86 Million | -56.99 Million | 2.6 Billion | 253.57 Million | 137.03 Million | -150.52 Million |
| Depreciation & Amortization | 121.67 Million | 126.01 Million | 125.12 Million | 166.28 Million | 116.18 Million | 113.72 Million |
| Deferred income taxes | -1.84 Million | 4.96 Million | 11.44 Million | -3.1 Million | -8.62 Million | 2.59 Million |
| Stock-based compensation | - | - | - | - | - | -16.2 Million |
| Change in working capital | -303.29 Million | 104.3 Million | 471.45 Million | -297.05 Million | -171.35 Million | -32.26 Million |
| Other non-cash items | 10.01 Million | -87 Million | -2.92 Billion | 99.13 Million | 104.48 Million | 223.54 Million |
| Investing Cash Flow | 472.83 Million | 2.39 Billion | 348.85 Million | 44.16 Million | -29.09 Million | -44.51 Million |
| Investments in PPE | -116.21 Million | -145.81 Million | -151.66 Million | -183.95 Million | -19.36 Million | -23.91 Million |
| Acquisitions | - | 1.08 Million | 4.96 Billion | 197.61 Million | 1.86 Million | 23.91 Million |
| Investment purchases | -8.3 Billion | -17.09 Billion | -8.88 Billion | -2.06 Billion | -3.02 Billion | -2.62 Billion |
| Sales/Maturities of investments | 8.89 Billion | 19.63 Billion | 4.42 Billion | 2.27 Billion | 3.01 Billion | 2.59 Billion |
| Other Investing Activities | 589.05 Million | -4.98 Million | 0.88 | -183.95 Million | 240.2 Thousand | -23.91 Million |
| Financing Cash Flow | -144.57 Million | -2.97 Billion | -386.45 Million | 205.61 Million | -356.5 Million | -26.08 Million |
| Debt repayment | -20.9 Million | -379.54 Million | -630.48 Million | -396.66 Million | -467.31 Million | -450.28 Million |
| Dividends payments | -1.22 Million | -2.77 Billion | -174.67 Million | -51.37 Million | -18.69 Million | -53.87 Million |
| Common Stock Repurchased | -110.66 Million | -256.45 Million | - | -120.17 Million | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -122.44 Million | 187.09 Million | 439.12 Million | 680.54 Million | 129.5 Million | 478.06 Million |
| Accounts receivables | 97.98 Million | 319.56 Million | 303.07 Million | -202.14 Million | -127.9 Million | 292.48 Million |
| Accounts payables | -266.99 Million | -78.98 Million | 320.11 Million | 163.59 Million | -5.9 Million | -240.15 Million |
| Inventory | -132.44 Million | -141.24 Million | -163.18 Million | -255.4 Million | -28.92 Million | -87.17 Million |
| Other working capital | -3.74 Million | 4.96 Million | 11.44 Million | -3.1 Million | -8.62 Million | 54.91 Million |
| Cash at beginning of period | 683.72 Million | 1.18 Billion | 937.27 Million | 465.55 Million | 664.8 Million | 580.93 Million |
| Cash at end of period | 762.81 Million | 683.72 Million | 1.18 Billion | 937.27 Million | 465.55 Million | 664.8 Million |
| Capital Expenditure | -116.21 Million | -145.81 Million | -151.66 Million | -183.95 Million | -19.36 Million | -23.91 Million |
| Effect of forex changes on cash | 1.00 | 0.35 | 0.09 | - | 0.36 | -0.32 |
| Net cash flow / Change in cash | 79.09 Million | -500.39 Million | 246.84 Million | 471.71 Million | -199.24 Million | 83.87 Million |
| Free Cash Flow | -365.38 Million | -59.5 Million | 132.78 Million | 37.98 Million | 166.98 Million | 130.55 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 9.46 Million | 7.55 Million | 23.1 Million | -47.86 Million | -43.1 Million | -15.41 Million |
| Depreciation & Amortization | - | 29.89 Million | 29.89 Million | 121.67 Million | 121.67 Million | -58.52 Million |
| Deferred income taxes | - | - | - | -1.84 Million | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | 30.92 Million | - | -303.29 Million | -38.2 Million | 14.25 Million |
| Other non-cash items | -81.7 Million | 27.02 Million | -30.34 Million | 10.01 Million | -66.26 Million | -47.14 Million |
| Investing Cash Flow | -29.24 Million | -100.77 Million | -43.84 Million | 472.83 Million | -160.67 Million | 205.4 Million |
| Investments in PPE | -90.89 Million | -69.4 Million | -71.84 Million | -116.21 Million | -45.26 Million | -22.59 Million |
| Acquisitions | -2.08 | 2.57 Million | 5.05 Million | - | -662.5 Thousand | 662.5 Thousand |
| Investment purchases | -1.19 Billion | -1.64 Billion | -2.16 Billion | -8.3 Billion | -2.68 Billion | -2.1 Billion |
| Sales/Maturities of investments | 1.25 Billion | 1.6 Billion | 2.18 Billion | 8.89 Billion | 2.57 Billion | 2.32 Billion |
| Other Investing Activities | 2.23 Million | -31.37 Million | 28 Million | 589.05 Million | -115.41 Million | 0.13 |
| Financing Cash Flow | 9.96 Million | -61.71 Million | -83.85 Million | -144.57 Million | 11.24 Million | 885.37 Thousand |
| Debt repayment | -4.67 Million | -39.77 Million | -3.56 Million | -20.9 Million | -902.19 Thousand | - |
| Dividends payments | -84.29 Thousand | -194.27 Thousand | -227.19 Thousand | -1.22 Million | -225.94 Thousand | -320.85 Thousand |
| Common Stock Repurchased | 102.75 Million | -102.75 Million | - | -110.66 Million | -55.33 Million | -55.33 Million |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | 14.72 Million | -21.74 Million | -87.18 Million | -122.44 Million | 12.36 Million | 1.2 Million |
| Accounts receivables | - | -25.07 Million | - | 97.98 Million | 97.98 Million | -55.62 Million |
| Accounts payables | - | - | - | -266.99 Million | - | - |
| Inventory | - | 57.53 Million | - | -132.44 Million | -132.44 Million | 67.95 Million |
| Other working capital | - | -1.53 Million | - | -3.74 Million | -3.74 Million | 1.92 Million |
| Cash at beginning of period | 441.09 Million | 611.24 Million | 762.81 Million | 683.72 Million | 938.16 Million | 847.34 Million |
| Cash at end of period | 342.57 Million | 441.09 Million | 611.24 Million | 762.81 Million | 762.81 Million | 938.16 Million |
| Capital Expenditure | -90.89 Million | -69.4 Million | -71.84 Million | -116.21 Million | -45.26 Million | -22.59 Million |
| Effect of forex changes on cash | - | - | - | 1.00 | 938.16 Million | -8.64 Million |
| Net cash flow / Change in cash | -98.51 Million | -170.15 Million | -151.57 Million | 79.09 Million | -175.34 Million | 90.81 Million |
| Free Cash Flow | -163.13 Million | -64.71 Million | -79.09 Million | -365.38 Million | -71.17 Million | -129.41 Million |
BEKE
GALD
CHOICEIN
NATHUEC
300631
TKPHF